Sodegaura, Japan

Masamichi Hara


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masamichi Hara: Innovator in Radiopharmaceuticals

Introduction

Masamichi Hara is a notable inventor based in Sodegaura, Japan. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative work at Nihon Medi-Physics Company, Limited. His expertise in chemistry and radiology has led to advancements that benefit medical diagnostics and treatment.

Latest Patents

Masamichi Hara holds a patent for a bisphosphonic acid derivative and a compound thereof labeled with a radioactive nuclide. This invention is crucial for enhancing the effectiveness of radiopharmaceuticals used in medical imaging and therapy. His work in this area demonstrates his commitment to improving healthcare through innovative solutions.

Career Highlights

Throughout his career, Hara has been dedicated to research and development in the field of medical technology. His role at Nihon Medi-Physics Company, Limited has allowed him to collaborate with other experts and contribute to groundbreaking advancements in radiopharmaceuticals. His patent reflects his innovative spirit and dedication to improving patient care.

Collaborations

Masamichi Hara has worked alongside talented colleagues, including Osamu Ito and Nobuhiko Kanazashi. Their collaborative efforts have fostered an environment of innovation and creativity, leading to significant advancements in their field.

Conclusion

Masamichi Hara is a distinguished inventor whose work in radiopharmaceuticals has made a lasting impact on medical technology. His patent and collaborations highlight his dedication to advancing healthcare solutions. His contributions continue to inspire future innovations in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…